| MCX: PRTK | |
| Founded | 1990 |
| Headquarters | , Russia |
| Revenue | $4.43 billion[1] (2017) |
| $138 million[1] (2017) | |
| $101 million[1] (2017) | |
| Total assets | $2.32 billion[1] (2017) |
| Total equity | $579 million[1] (2017) |
Number of employees | 15,300 |
Protek (Russian: Протек) is a Russian company that includes drug manufacturing, retail, and distribution. It is one of the largest pharmaceutical companies of Russia.[2] It was founded in 1990 by Vadim Yakunin and Grigor Khachaturov.[3] In 2022, the company's revenue in Russia amounted to 257 billion rubles.[4]
See also
References
- 1 2 3 4 5 Error: Unable to display the reference properly. See the documentation for details.
- ↑ "Russia - Country Commercial Guide - Pharmaceuticals". International Trade Administration (which operates trade.gov). 2020-11-14. Retrieved June 17, 2021.
- ↑ "Russian drug firm Protek in talks with new partner". Reuters. Archived from the original on 2022-12-18.
- ↑ "АО ЦВ Протек". www.rusprofile.ru (in Russian). Retrieved 2023-11-30.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.